Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
TLX
Fundamentals

Telix Pharmaceuticals Ltd

TLX

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

783.21M
▲280.66M▲55.85%
12 Months Change

Assets

1.52B
▲1.11B▲273.54%
12 Months Change

Liabilities

948.22M
▲691.17M▲268.89%
12 Months Change

Free Cash Flow

28.71M
▲14.50M▲102.09%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2026-02-20
Form 20-F
ID: 0001628280-26-009943
2025-02-24
Form 20-F
ID: 0001140361-25-005562